Author:
Mohan Divya,Nambirajan Aruna,Malik Rafat,Sharma Agrima,Suri Vaishali,Kaur Kavneet,Doddamani Ramesh,Garg Ajay,Gupta Subhash,Mallick Supriya,Sharma Mehar Chand
Funder
Indian Council of Medical Research
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Figarella-Branger D, Appay R, Metais A, Tauziède-Espariat A, Colin C, Rousseau A, Varlet P. La classification de l’OMS 2021 des tumeurs du système nerveux central [The 2021 WHO classification of tumours of the central nervous system]. Ann Pathol. 2022;42(5):367–82.
2. Nambirajan A, Sharma MC. Evaluation of surrogate immunohistochemical markers for molecularly defined neoplasms of the central nervous system: need of the hour. Neurol India. 2020;68(4):838–9.
3. Ellison DW, Figarella-Branger D. Ependymal tumours: introduction. In: WHO Classification of Tumours Editorial Board. Central nervous system tumours. Lyon (France): International Agency for Research on Cancer; 2021. WHO classification of tumours series, 5th edn, vol 6. https://publications.iarc.fr/601. Accessed 22 Feb 2024.
4. Nambirajan A, Sharma MC, Gupta RK, Suri V, Singh M, Sarkar C. Study of stem cell marker nestin and its correlation with vascular endothelial growth factor and microvascular density in ependymomas. Neuropathol Appl Neurobiol. 2014;40(6):714–25.
5. Malgulwar PB, Sharma V, Tomar AS, Verma C, Nambirajan A, Singh M, Suri V, Sarkar C, Sharma MC. Transcriptional co-expression regulatory network analysis for Snail and Slug identifies IL1R1, an inflammatory cytokine receptor, to be preferentially expressed in ST-EPN-RELA and PF-EPN-A molecular subgroups of intracranial ependymomas. Oncotarget. 2018;9(84):35480–92.